VYSIONEER Collaborates with MC Medical to Introduce the First-ever Brain Tumor Auto Contouring AI for Radiotherapy to Japan
Vysioneer, a leading innovator in Oncology AI, is proud to announce a strategic collaboration with MC Medical, a subsidiary of Mitsubishi Corporation and a wholly owned subsidiary of MC Healthcare Holdings for bringing advanced medical device around the world to Japan….
International Association for the Study of Lung Cancer (IASLC) and Lung Cancer Research Foundation (LCRF) Announce Request for Proposals
The Lung Cancer Research Foundation announced today that, in partnership with the International Association for the Study of Lung Cancer, submissions are being accepted for the $2.5 million, four-year award, titled IASLC-LCRF Team Science Research Grant on Advancing Therapies Towards Curing Oncogenic-Driven…
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
Inspira Technologies OXY B.H.N Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, has announced the signing of a non-binding Letter of Intent (LOI) with Northwestern Memorial Hospital in Chicago, Illinois (“Northwestern”)….
New Drug Application of Mabwell’s 8MW0511 for Injection Accepted by NMPA
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug application of its recombinant (yeast-secreted) human serum albumin-human granulocyte colony-stimulating factor (I) fusion protein for injection (R&D code: 8MW0511) has been accepted by the National…
RNAimmune Receives Investigational New Drug Application Clearance from U.S. FDA for mRNA-Based Respiratory Syncytial Virus Vaccine RV-1770
Sirnaomics Ltd. (the “Company”, Stock Code: 2257, together with its subsidiaries, the “Group” or “Sirnaomics”), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that, its subsidiary RNAimmune, Inc. (“RNAimmune”), a leading biotech company specializing in mRNA-based vaccines…
Sterling Accuris expands into pharmaceutical and analytical testing through a new partnership
Sterling Accuris Diagnostics, a leading chain of NABL-accredited pathology laboratories has announced theacquisition of Ahmedabad based Vaibhav Analytical Services, a leading provider of analytical testing services, including pharmaceutical/drug testing.With this acquisition, Sterling Accuris has successfully expanded its range of services…
Sightsavers India’s Eight–State Inclusive Education Programme Bags the Zero Award 2024
Sightsavers India won the Zero Project Award 2024 for its Eight–State Inclusive Education Programme’s concerted effort for using accessible Information and Communication Technology (ICT) devices. The initiative stood out among 523 nominations from 97 countries, earning recognition from an international…
Diabetic Tussin Reintroduces Sugar-Free Cold and Cough Solution for People with Diabetes
Today, Diabetic Tussin®, the trusted cough syrup brand for people with diabetes and prediabetes, announces its sugar-free cold and cough solution is back on shelves. This restock brings with it the Better Choices for Life mark from the American Diabetes…
HeiQ unveils HeiQ Skin Care – a probiotics-infused textile technology
HeiQ introduces a 100% biobased and long-lasting cosmetic finishing technology for textiles to the market. The newest addition to the HeiQ portfolio harnesses the power of active probiotics and selected prebiotics to enhance the skin microbiome, turning the human’s largest organ…
PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics using Artificial Intelligence
PostEra, a biotechnology company specializing in artificial intelligence for preclinical drug discovery, today announced a multi-target collaboration with Amgen, a leading biotechnology company. The collaboration will leverage PostEra’s AI platform, Proton, a pioneering innovation in generative chemistry and synthesis-aware design, and…
